Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

202

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

202 results for “eczema”

Learn how ShareScore rates datasets ↗
zenodo40/100

Skin care interventions for preventing eczema and food allergy: RoB 2 assessments

<p>This excel file contains the detailed risk of bias assessment data, with consensus responses to the signalling questions, using the Cochrane Risk of bias 2 tool for&nbsp;Kelleher MM, Cro S, Cornelius V, Axon E, Lodrup Carlsen KC, Skjerven HOve, Rehbinder EMaria, Lowe A, Dissanayake E, Shimojo N, Yonezawa K, Ohya Y, Yamamoto-Hanada K, Morita K, Surber C, Cork M, Cooke A, Tran L, Askie LM, Duley L, Van Vogt E, Chalmers JR, Williams HC, Boyle RJ. Skincare interventions in infants for preventing eczema and food allergy. Cochrane Database of Systematic Reviews 2020, Issue 2. Art. No.: CD013534. DOI: 10.1002/14651858.CD013534.</p>

opencc-by-4.0Aug 2020View details →
ClinicalTrials.gov36/100

Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema

ClinicalTrials.gov study NCT00817063. IPD Sharing: YES. Countries: 1. Publications: 4.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 1 (ECZema TRAlokinumab Trial no. 1)

ClinicalTrials.gov study NCT03131648. IPD Sharing: NO. Countries: 5. Publications: 9.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Phase 2b Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over a 16-week Treatment Period in Adult Subjects With Chronic Hand Eczema

ClinicalTrials.gov study NCT03683719. IPD Sharing: NO. Countries: 3. Publications: 3.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).

ClinicalTrials.gov study NCT03526861. IPD Sharing: NO. Countries: 10. Publications: 4.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Study to Evaluate ASN002 in Subjects With Moderate To Severe Chronic Hand Eczema

ClinicalTrials.gov study NCT03728504. IPD Sharing: UNDECIDED. Countries: 2. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema (DELTA 2)

ClinicalTrials.gov study NCT04872101. IPD Sharing: NO. Countries: 7. Publications: 2.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Tofacitinib Ointment For Atopic Dermatitis (Atopic Eczema)

ClinicalTrials.gov study NCT02001181. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Human Testing of an Over-the-Counter (OTC) Cream in Children With Eczema

ClinicalTrials.gov study NCT01326910. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

A Study to Determine the Safety and Tolerability of Dupilumab (REGN668/SAR231893) in Patients Aged ≥6 to <18 Years With Atopic Dermatitis (Eczema)

ClinicalTrials.gov study NCT02407756. IPD Sharing: Not stated. Countries: 6. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema)

ClinicalTrials.gov study NCT03569293. IPD Sharing: YES. Countries: 25. Publications: 13.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Treatment of Staphylococcus Aureus Colonization in Hand Eczema

ClinicalTrials.gov study NCT01591785. IPD Sharing: Not stated. Countries: 1. Publications: 11.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Efficacy and Safety of Delgocitinib Cream in Adolescents 12-17 Years of Age With Moderate to Severe Chronic Hand Eczema

ClinicalTrials.gov study NCT05355818. IPD Sharing: NO. Countries: 7. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Impact of Regular Consumption of Eggs and Nutrients Fortified Eggs on Eczema Condition in Singapore Individuals

ClinicalTrials.gov study NCT06454942. IPD Sharing: NO. Countries: 1. Publications: 2.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

A Community-based Assessment of Skin Care, Allergies, and Eczema

ClinicalTrials.gov study NCT03409367. IPD Sharing: YES. Countries: 1. Publications: 2.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 2 (ECZema TRAlokinumab Trial no. 2)

ClinicalTrials.gov study NCT03160885. IPD Sharing: NO. Countries: 9. Publications: 7.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema

ClinicalTrials.gov study NCT04871711. IPD Sharing: NO. Countries: 6. Publications: 4.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

A 24 Week Trial to Compare the Efficacy and Safety of Delgocitinib Cream 20 mg/g Twice-daily With Alitretinoin Capsules Once-daily in Adult Participants With Severe Chronic Hand Eczema

ClinicalTrials.gov study NCT05259722. IPD Sharing: NO. Countries: 10. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Skin bioMARkers for Atopic Eczema Therapy Evaluation

ClinicalTrials.gov study NCT04194814. IPD Sharing: NO. Countries: 1. Publications: 24.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Omega-3 Monoglyceride Based Topic Products as Skin Prebiotics for Eczema

ClinicalTrials.gov study NCT06155513. IPD Sharing: NO. Countries: 1. Publications: 4.

closedIPD-NOFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record